GSK Gsk Plc

TIDMGSK

RNS Number : 5230H

GlaxoSmithKline PLC

03 December 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  ============================================ 
 b)   Position/status          SVP & General Counsel 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            The grant of options over Ordinary Shares 
       transaction              pursuant to the Company's Sharesave Plan 
                                2012 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                  GBP10.34    870 
                                             ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2020-11-27 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  ============================================ 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            The grant of options over Ordinary Shares 
       transaction              pursuant to the Company's Sharesave Plan 
                                2012 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                  GBP10.34    870 
                                             ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2020-11-27 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDXLFBBLLEFBF

(END) Dow Jones Newswires

December 03, 2020 12:53 ET (17:53 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024